KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Cash from Financing Activities (2016 - 2025)

Petmed Express' Cash from Financing Activities history spans 16 years, with the latest figure at -$231000.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 225.35% year-over-year to -$231000.0; the TTM value through Dec 2025 reached -$266000.0, down 37.11%, while the annual FY2025 figure was -$181000.0, 98.54% up from the prior year.
  • Cash from Financing Activities reached -$231000.0 in Q3 2025 per PETS's latest filing, down from -$30000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of -$1000.0 in Q4 2024 to a low of -$6.3 million in Q3 2023.
  • Average Cash from Financing Activities over 5 years is -$3.5 million, with a median of -$6.0 million recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 99.75% in 2023, then crashed 225.35% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$6.1 million in 2021, then dropped by 0.54% to -$6.1 million in 2022, then surged by 99.75% to -$15000.0 in 2023, then surged by 93.33% to -$1000.0 in 2024, then plummeted by 23000.0% to -$231000.0 in 2025.
  • Per Business Quant, the three most recent readings for PETS's Cash from Financing Activities are -$231000.0 (Q3 2025), -$30000.0 (Q2 2025), and -$5000.0 (Q1 2025).